ask="N/A"
ask_size="N/A"
average_daily_volume="31502"
bid="3.12"
bid_size="100"
book_value="3.34"
change="+0.42"
change_from_200_day_moving_average="5.32"
change_from_50_day_moving_average="2.67"
change_from_52_week_high="-0.37"
change_From_52_week_low="8.86"
change_in_percent="+3.51%"
close="12.38"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.53"
eps_estimate_next_quarter="-0.60"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="N/A"
high="12.50"
high_52_weeks="12.75"
last_trade_date="3/9/2017"
last_trade_price="12.38"
last_trade_size="114"
last_trade_time="4:00pm"
low="11.70"
low_52_weeks="3.52"
market_capitalization="263.45M"
moving_average_200_day="7.06"
moving_average_50_day="9.71"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="15.81"
open="12.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+75.38%"
percent_change_from_50_day_moving_average="+27.46%"
percent_change_from_52_week_high="-2.90%"
percent_change_from_52_week_low="+251.70%"
previous_close="11.96"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.58"
price_per_sales="48.94"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.35"
stock_exchange="NMS"
symbol="NBRV"
volume="34844"
weeks_range_52="3.52 - 12.75"
